The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases
- PMID: 15564047
- DOI: 10.1016/j.tcb.2004.10.006
The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases
Abstract
During the past decade, it has become apparent that a set of ostensibly unrelated neurodegenerative diseases, including Parkinson's disease and Huntington's disease, shares striking molecular and cell biology commonalities. Each of the diseases involves protein misfolding and aggregation, resulting in inclusion bodies and other aggregates within cells. These aggregates often contain ubiquitin, which is the signal for proteolysis by the 26S proteasome, and chaperone proteins that are involved in the refolding of misfolded proteins. The link between the ubiquitin-proteasome system and neurodegeneration has been strengthened by the identification of disease-causing mutations in genes coding for several ubiquitin-proteasome pathway proteins in Parkinson's disease. However, the exact molecular connections between these systems and pathogenesis remain uncertain and controversial. In this article, we summarize the state of current knowledge, focusing on important unresolved questions.
Similar articles
-
A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.Nat Neurosci. 2008 Mar;11(3):301-8. doi: 10.1038/nn2058. Epub 2008 Feb 24. Nat Neurosci. 2008. PMID: 18297066
-
Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?J Alzheimers Dis. 2010;19(1):1-9. doi: 10.3233/JAD-2010-1231. J Alzheimers Dis. 2010. PMID: 20061621 Review.
-
Ubiquitin-proteasome system and Parkinson's disease.Mov Disord. 2006 Nov;21(11):1806-23. doi: 10.1002/mds.21013. Mov Disord. 2006. PMID: 16972273 Review.
-
The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.Trends Mol Med. 2005 Nov;11(11):488-95. doi: 10.1016/j.molmed.2005.09.001. Epub 2005 Oct 6. Trends Mol Med. 2005. PMID: 16213790 Review.
-
Ubiquitin proteasome system as a pharmacological target in neurodegeneration.Expert Rev Neurother. 2006 Sep;6(9):1337-47. doi: 10.1586/14737175.6.9.1337. Expert Rev Neurother. 2006. PMID: 17009921 Review.
Cited by
-
Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting.Mol Biol Cell. 2013 Jul;24(13):2076-87. doi: 10.1091/mbc.E13-01-0010. Epub 2013 May 1. Mol Biol Cell. 2013. PMID: 23637465 Free PMC article.
-
Proteasome inhibition induces hsp30 and hsp70 gene expression as well as the acquisition of thermotolerance in Xenopus laevis A6 cells.Cell Stress Chaperones. 2010 May;15(3):323-34. doi: 10.1007/s12192-009-0147-4. Epub 2009 Oct 18. Cell Stress Chaperones. 2010. PMID: 19838833 Free PMC article.
-
Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression.J Biol Chem. 2010 Jul 9;285(28):21736-49. doi: 10.1074/jbc.M109.099283. Epub 2010 Apr 21. J Biol Chem. 2010. PMID: 20410307 Free PMC article.
-
Nuclear polyglutamine-containing protein aggregates as active proteolytic centers.J Cell Biol. 2008 Feb 25;180(4):697-704. doi: 10.1083/jcb.200708131. Epub 2008 Feb 18. J Cell Biol. 2008. PMID: 18283109 Free PMC article.
-
The ubiquitin-like protein PLIC-1 or ubiquilin 1 inhibits TLR3-Trif signaling.PLoS One. 2011;6(6):e21153. doi: 10.1371/journal.pone.0021153. Epub 2011 Jun 17. PLoS One. 2011. PMID: 21695056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous